pubs_raw.json  // 논문에 대한 공동저자와 제목, 키워드, 베너, abstract가 적혀있다.
"5b5433e8e1cd8e4e15fd598f":
 {"authors": [{"name": "Li Fan", "org": "Department of Medical Oncology", "id": "5b5433e6e1cd8e4e15fa4acb"}, 
{"name": "Jun Ren", "org": "Department of Medical Oncology", "id": "5b5433eae1cd8e4e15032338"}, 
{"name": "Wenchao Liu", "org": "Department of Medical Oncology", "id": "5b5433f0e1cd8e4e150f55f3"}, 
{"name": "Yongqi Li", "org": "Department of Medical Oncology", "id": "5b5433f0e1cd8e4e150f6fb6"}, 
{"name": "Le Ge", "org": "Department of Medical Oncology", "id": "5b5433ece1cd8e4e1507c9b2"}, 
{"name": "Rong Sheng", "org": "Department of Medical Oncology", "id": "5b5433f5e1cd8e4e1519acb2"},
 {"name": "Yanjun Zhang", "org": "Department of Medical Oncology", "id": "5b5433f1e1cd8e4e1511294d"}, 
{"name": "Yanguang Zhu", "org": "Department of Medical Oncology", "id": "5b5433f0e1cd8e4e1510a61c"}], 
"title": "Pharmacoeconomic analysis of three new chemotherapeutic regimens for non-small cell lung cancer", 
"keywords": ["Cost-effectiveness analysis", "Non-small cell lung cancer", "Pharmacoeconomic analysis"],
 "venue": "Chinese Journal of Lung Cancer", "year": 2002,
 "abstract": "Objective: To evaluate three new chemotherapeutic regimens for non-small cell lung cancer (NSCLC) by pharmacoeconomic analysis in guiding rational use of drugs. Methods: One hundred and one cases of NSCLC in clinic stage III or IV were treated by one of the three chemotherapeutic schemes-PC: paclitaxel (135 mg/m"}, 



5b5433e8e1cd8e4e15fd598f-0	__NAME__jun_ren __NAME__wenchao_liu __NAME__yongqi_li __NAME__le_ge __NAME__rong_sheng __NAME__yanjun_zhang __NAME__yanguang_zhu
				 __ORG__department_of_medical_oncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology 
				__TITLE__pharmacoeconom __TITLE__analysi __TITLE__of __TITLE__three __TITLE__new __TITLE__chemotherapeut __TITLE__regimen __TITLE__for __TITLE__non-smal __TITLE__cell __TITLE__lung __TITLE__cancer 
				__KEYWORD__cost_effectiveness_analysis __KEYWORD__non_small_cell_lung_cancer __KEYWORD__pharmacoeconomic_analysis __VENUE__chinese __VENUE__journal __VENUE__of __VENUE__lung __VENUE__cancer


authors_features.txt
5b5433e8e1cd8e4e15fd598f-1	__NAME__li_fan __NAME__wenchao_liu __NAME__yongqi_li __NAME__le_ge __NAME__rong_sheng __NAME__yanjun_zhang __NAME__yanguang_zhu __ORG__department_of_medical_oncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __TITLE__pharmacoeconom __TITLE__analysi __TITLE__of __TITLE__three __TITLE__new __TITLE__chemotherapeut __TITLE__regimen __TITLE__for __TITLE__non-smal __TITLE__cell __TITLE__lung __TITLE__cancer __KEYWORD__cost_effectiveness_analysis __KEYWORD__non_small_cell_lung_cancer __KEYWORD__pharmacoeconomic_analysis __VENUE__chinese __VENUE__journal __VENUE__of __VENUE__lung __VENUE__cancer
5b5433e8e1cd8e4e15fd598f-2	__NAME__li_fan __NAME__jun_ren __NAME__yongqi_li __NAME__le_ge __NAME__rong_sheng __NAME__yanjun_zhang __NAME__yanguang_zhu __ORG__department_of_medical_oncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __TITLE__pharmacoeconom __TITLE__analysi __TITLE__of __TITLE__three __TITLE__new __TITLE__chemotherapeut __TITLE__regimen __TITLE__for __TITLE__non-smal __TITLE__cell __TITLE__lung __TITLE__cancer __KEYWORD__cost_effectiveness_analysis __KEYWORD__non_small_cell_lung_cancer __KEYWORD__pharmacoeconomic_analysis __VENUE__chinese __VENUE__journal __VENUE__of __VENUE__lung __VENUE__cancer
5b5433e8e1cd8e4e15fd598f-3	__NAME__li_fan __NAME__jun_ren __NAME__wenchao_liu __NAME__le_ge __NAME__rong_sheng __NAME__yanjun_zhang __NAME__yanguang_zhu __ORG__department_of_medical_oncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __TITLE__pharmacoeconom __TITLE__analysi __TITLE__of __TITLE__three __TITLE__new __TITLE__chemotherapeut __TITLE__regimen __TITLE__for __TITLE__non-smal __TITLE__cell __TITLE__lung __TITLE__cancer __KEYWORD__cost_effectiveness_analysis __KEYWORD__non_small_cell_lung_cancer __KEYWORD__pharmacoeconomic_analysis __VENUE__chinese __VENUE__journal __VENUE__of __VENUE__lung __VENUE__cancer
5b5433e8e1cd8e4e15fd598f-4	__NAME__li_fan __NAME__jun_ren __NAME__wenchao_liu __NAME__yongqi_li __NAME__rong_sheng __NAME__yanjun_zhang __NAME__yanguang_zhu __ORG__department_of_medical_oncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __TITLE__pharmacoeconom __TITLE__analysi __TITLE__of __TITLE__three __TITLE__new __TITLE__chemotherapeut __TITLE__regimen __TITLE__for __TITLE__non-smal __TITLE__cell __TITLE__lung __TITLE__cancer __KEYWORD__cost_effectiveness_analysis __KEYWORD__non_small_cell_lung_cancer __KEYWORD__pharmacoeconomic_analysis __VENUE__chinese __VENUE__journal __VENUE__of __VENUE__lung __VENUE__cancer
5b5433e8e1cd8e4e15fd598f-5	__NAME__li_fan __NAME__jun_ren __NAME__wenchao_liu __NAME__yongqi_li __NAME__le_ge __NAME__yanjun_zhang __NAME__yanguang_zhu __ORG__department_of_medical_oncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __TITLE__pharmacoeconom __TITLE__analysi __TITLE__of __TITLE__three __TITLE__new __TITLE__chemotherapeut __TITLE__regimen __TITLE__for __TITLE__non-smal __TITLE__cell __TITLE__lung __TITLE__cancer __KEYWORD__cost_effectiveness_analysis __KEYWORD__non_small_cell_lung_cancer __KEYWORD__pharmacoeconomic_analysis __VENUE__chinese __VENUE__journal __VENUE__of __VENUE__lung __VENUE__cancer
5b5433e8e1cd8e4e15fd598f-6	__NAME__li_fan __NAME__jun_ren __NAME__wenchao_liu __NAME__yongqi_li __NAME__le_ge __NAME__rong_sheng __NAME__yanguang_zhu __ORG__department_of_medical_oncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __TITLE__pharmacoeconom __TITLE__analysi __TITLE__of __TITLE__three __TITLE__new __TITLE__chemotherapeut __TITLE__regimen __TITLE__for __TITLE__non-smal __TITLE__cell __TITLE__lung __TITLE__cancer __KEYWORD__cost_effectiveness_analysis __KEYWORD__non_small_cell_lung_cancer __KEYWORD__pharmacoeconomic_analysis __VENUE__chinese __VENUE__journal __VENUE__of __VENUE__lung __VENUE__cancer
5b5433e8e1cd8e4e15fd598f-7	__NAME__li_fan __NAME__jun_ren __NAME__wenchao_liu __NAME__yongqi_li __NAME__le_ge __NAME__rong_sheng __NAME__yanjun_zhang __ORG__department_of_medical_oncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __ORG__departmentofmedicaloncology __TITLE__pharmacoeconom __TITLE__analysi __TITLE__of __TITLE__three __TITLE__new __TITLE__chemotherapeut __TITLE__regimen __TITLE__for __TITLE__non-smal __TITLE__cell __TITLE__lung __TITLE__cancer __KEYWORD__cost_effectiveness_analysis __KEYWORD__non_small_cell_lung_cancer __KEYWORD__pharmacoeconomic_analysis __VENUE__chinese __VENUE__journal __VENUE__of __VENUE__lung __VENUE__cancer


아래꺼 양식 pubs_raw.json
논문 이름  { 저자들 정보들 } { 논문에 대한 간단한 정보 }
 "5b5433f4e1cd8e4e15177460": {"authors": [{"name": "Bo Yang", "org": "College of Chemistry and Molecular Engineering", "id": "5b5433f6e1cd8e4e151da212"}, {"name": "Yanjun Zhang", "org": "College of Information and Control Engineering", "id": "5b5433f1e1cd8e4e1511294d"}, {"name": "Shusheng Zhang", "org": "College of Chemistry and Molecular Engineering", "id": "5b5433ece1cd8e4e15080e44"}, {"name": "T. Izumi", "org": "Division of Engineering", "id": "5b5433e7e1cd8e4e15fb8187"}], "title": "Amidation of amines with esters catalyzed by Candida antarctica lipase (CAL)", "venue": "Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry", "year": 2005, "abstract": "Candida antarctica lipase (CAL) is used to convert amines and esters into amides, especially as a chiral resoluting catalyst for the enantioselective amidation of racemic esters or racemic amines in an effort to demonstrate the ability of lipase to differentiate between enantiomeric substrates. It is a very useful synthetic method for amides. The effects of substrate modification on the yield and enantiomeric excess (ee) are studied. The R-enantiomer will react faster for racemic mixture of amine in which the amino group attaches directly to the chiral carbon, and the same for racemic mixture of ester in which the carbonyl group attaches directly to the chiral carbon. The enantioselectivity of CAL is complicated for the amidation of racemic mixture of amine with racemic mixture of ester."}, 


name_to_pubs_train_500.json
사람이름 :{
   { 사람 id :
	{ 논문들 id: {
	}
      }
}
		